The Advanced Bionics HiRes Ultra 3D cochlear implant.
The Advanced Bionics HiRes Ultra 3D cochlear implant.

VALENCIA, CALIF — Advanced Bionics (AB), a global leader in cochlear implant technology, has announced an equity investment and research collaboration with Spiral Therapeutics, a company dedicated to advancing innovative approaches for disorders of the inner ear.

This collaboration brings together Advanced Bionics’ three decades of expertise in cochlear implant innovation with Spiral Therapeutics’ pioneering work in precision drug delivery technologies for the inner ear. The effort aims to explore how novel drug-delivery methods could support AB’s long-term innovation roadmap and the broader future of cochlear implant technology.

Through this collaboration, we are combining two highly complementary R&D capabilities to explore what could become a new innovation chapter in cochlear implant technology. Our focus is firmly on responsible, science-driven development that has the potential to benefit patients in meaningful ways over time.

Fernando Chapa, AB Senior Vice President, Global R&D
ADVERTISEMENTad for Phonak

Spiral Therapeutics’ novel drug‑delivery platform is designed to enable minimally invasive, precise, and durable exposure of therapeutics to the cochlea. Within the scope of this early‑stage R&D collaboration, the companies will investigate how such a platform could be utilized during cochlear implant surgery to explore solutions for important unmet needs in the field.

Advanced Bionics continues to invest in breakthrough technologies that strengthen its leadership in cochlear implant innovation and advance its mission to deliver consistently better outcomes for people living with hearing loss.

For more information, please visit the Advanced Bionics website.

SOURCE: Advanced Bionics

  • HearingTracker Staff